BioJapan 2026 Guide: Partnering, Meetings & Japan Market Entry

In 2025, BioJapan and its two co-located events — Regenerative Medicine JAPAN and healthTECH JAPAN — welcomed 22,167 visitors and 1,134 exhibiting companies. The Partnering program brought together 1,568 companies and 3,073 attendees, generating 25,498 meetings. Organizations from 39 countries and regions were represented.

For an overseas biotech company, the challenge is not simply finding potential contacts. It is identifying which organizations are most relevant to your technology, development stage, and objectives in Japan.

This guide covers the practical side of preparing for BioJapan 2026: how the event and Partnering System work, how to identify and prioritize potential partners, how to prepare for meetings, and how to use BioJapan as part of a broader Japan market-entry strategy.

BioJapan 2026 at a Glance

BioJapan 2026 will take place from October 7–9, 2026, from 10:00 to 17:00 at PACIFICO Yokohama. The 2026 event marks the 40th anniversary of BioJapan, which was first held in 1986.

The organizer describes BioJapan as Asia's premier bio-industry partnering event and states on its official website that it is the world's longest-running biotech exhibition.

BioJapan is built around three main components:

• Exhibition — opportunities to connect with potential partners and customers
• Seminars — presentations from researchers, biotech executives, and other industry experts covering technologies and industry trends
• Partnering — a dedicated system for identifying potential partners and arranging meetings before the event

BioJapan 2026 is also held alongside two co-located events:

• Regenerative Medicine JAPAN — focused on accelerating R&D and commercialization in regenerative medicine
• healthTECH JAPAN — focused on the integration of digital technology and life sciences across healthcare, diagnostics, and therapeutics

BioJapan extends beyond pharmaceuticals. Its exhibition covers areas including drug discovery, diagnostics, research tools, bioinformatics, CRO/CMO services, food and agriculture, chemicals, energy, intellectual property, finance, academia, and public organizations.

For overseas biotech companies focused on partnerships, licensing, research collaboration, or business development, however, one of the most relevant parts of the event is the Partnering System.

How Large Is BioJapan?

The previous event provides useful context for the scale of the opportunity.

In 2025, BioJapan, Regenerative Medicine JAPAN, and healthTECH JAPAN together recorded:

Participating countries and regions included the United States, Canada, the United Kingdom, Australia, Switzerland, Germany, France, Singapore, South Korea, and many others.

For an overseas biotech company, that scale is attractive.

But it also illustrates why target selection before the event matters.

With more than 1,500 companies participating in Partnering in 2025, researching and approaching everyone is neither realistic nor useful.

Which organizations are worth your limited meeting time?

Free Attendance vs. Paid Partnering

BioJapan offers two main participation options: free visitor admission and paid Partnering.

Free Visitor Admission

Free attendance provides access to:

• The exhibition
• Exhibitor presentations
• Seminars, with pre-registration required where applicable

This option can be useful if your primary objectives are to explore the Japanese biotech ecosystem, attend seminars, discover companies and technologies, or meet contacts you already know.

Visitor registration for BioJapan 2026 opened in July, while exhibitor and seminar information became available in August. The official website also provides search functions for exhibitors, Partnering participants, seminars, and presentations.

Paid Partnering

Paid Partnering includes standard visitor access plus:

• Access to the Partnering System
• Access to the Partnering Area
• Access to the Networking Party

The Partnering System is designed to allow participants to identify target exhibitors or attendees and request appointments before the event, rather than relying only on chance encounters at the venue.

The system supports:

• Searching assets and needs
• Sending messages
• Requesting meetings
• Sending PDF files
• Scheduling meeting times and locations

According to the organizer, Partnering is used for purposes including joint R&D, service proposals, and the in- and out-licensing of assets.

Who Uses the Partnering System?

The composition of Partnering participants is particularly relevant for companies attending BioJapan for business development.

According to BioJapan's official 2026 information, the job functions represented include:

• Business Development / Licensing — 28%
• R&D — 20%

By industry, participants include:

• Drug Development Service — 21%
• Pharma — 18%
• Academia / Institutes — 14%
• CMO / CDMO — 7%

Business Development / Licensing and R&D professionals together account for approximately half of Partnering participants.

This makes the Partnering System particularly relevant for companies seeking concrete conversations around research collaboration, licensing, technology, or service opportunities rather than general market visibility alone.

BioJapan 2026 Partnering Fees and Schedule

For general participants, the 2026 Partnering fees are:

Prices include tax, and dates are based on Japan Standard Time (JST).

Partnering registration opened in July, and meeting requests began in August. The organizer encourages participants to take action early to increase the chances of their meeting requests being accepted.

The Partnering registration deadline itself is 16:00 JST on October 9, 2026, although companies planning to use the system strategically will naturally want to register and begin approaching targets much earlier.

Another important point for overseas teams is that only one person can register per account. A single account cannot be shared among multiple participants.

Start With Your Japan Objective — Not the Participant List

Once you have access to a large database of exhibitors and Partnering participants, it can be tempting to start searching company names immediately.

A better starting point is to define what you actually want to achieve in Japan.

If You Are Looking for a Licensing Partner

For a therapeutic asset, potential targets may include Japanese pharmaceutical companies with relevant therapeutic-area pipelines, evidence of external licensing activity, or strategic gaps that your asset could potentially address.

If You Are Looking for a Research Collaboration

Relevant targets may include pharmaceutical R&D teams, universities, principal investigators, and research institutes working on related targets, diseases, modalities, or technologies.

If You Are Looking for Customers

For an AI drug discovery platform, CRO, research tool, data platform, or other B2B technology, the key question may be which Japanese organizations have a concrete use case for the technology.

If You Are Looking for a Commercialization Partner

For diagnostics, medical devices, or other healthcare technologies, the ideal partner profile may depend on commercialization capabilities, regulatory experience, clinical relationships, or distribution infrastructure.

Different objectives produce very different target lists.

Before asking:

"Who is attending BioJapan?"

ask:

"What type of organization do we actually need to meet in Japan?"

Build a Prioritized Target List

Once the objective is clear, the BioJapan participant database becomes much more useful.

Rather than treating every company equally, evaluate potential targets against criteria relevant to your technology and business model.

Depending on the company, useful factors may include:

• Therapeutic area
• Modality or technology fit
• Relevant pipeline programs
• Recent licensing or collaboration activity
• Existing partnerships
• Potential use case
• Strategic relevance in Japan
• Relevant business unit
• Reason for requesting a meeting

The result should not simply be a spreadsheet of company names.

It should become a prioritized opportunity map.

• Tier 1 — High-priority targets. Strong scientific or commercial fit and a clear reason to meet.
• Tier 2 — Strategic possibilities. Potential fit, but important assumptions still need validation.
• Tier 3 — Exploratory targets. Useful for market learning, ecosystem development, or longer-term relationships.

For an overseas company spending only a few days in Japan, this prioritization can be particularly important.

Research Each Target Before Sending a Meeting Request

Being active in the same therapeutic area does not automatically make an organization a strong partner.

For a pharmaceutical company, for example, you might investigate:

• Does it have relevant assets in its pipeline?
• Which modalities does it actively develop?
• Has it recently licensed external assets?
• Does it collaborate with overseas biotech companies?
• Is there an identifiable strategic need that your technology could address?
• Which team is most likely to evaluate the opportunity?

Japanese-language sources can be particularly useful here.

Corporate press releases, R&D presentations, pipeline documents, investor materials, conference presentations, and public research databases may contain information that is less visible on English-language corporate websites.

The objective is not merely to determine:

"Is this a Japanese pharmaceutical company?"

It is to understand:

"Why might this specific organization have a reason to talk to us?"

Make Your Meeting Request Specific

BioJapan's Partnering System allows participants to send messages and PDF files before the event.

Use that opportunity to make the relevance of your request clear.

A generic message such as:

gives the recipient relatively little reason to prioritize the meeting.

Instead, communicate:

• What your company does
• Why you selected this organization
• Where you see potential alignment
• What you would like to discuss

The first message does not need to explain your entire technology platform. Its job is to answer a simpler question:

Why might this conversation be worth the recipient's time?

Prepare for a Short Meeting

BioJapan Partnering meetings take place within a limited time window.

That means your objective should not be to explain everything about your company. A more realistic goal is to determine whether there is enough mutual interest for a deeper conversation after BioJapan.

One possible structure is:

• First 3–5 minutes. Introduce your company and explain why you wanted to meet this organization.
• Next 5–10 minutes. Focus on the technology, asset, or use case most relevant to them.
• Next 5–10 minutes. Ask about their priorities, needs, evaluation process, and potential fit.
• Final minutes. Clarify whether there is a useful next step.

That next step might be a technical meeting, a CDA/NDA discussion, a data review, an introduction to another internal team, or a follow-up conversation after the event.

A successful BioJapan meeting does not necessarily need to end with a deal.

It may simply establish:

Is there a reason to continue the conversation, and what should happen next?

Use BioJapan for Market Validation, Not Only Lead Generation

BioJapan can also be useful for overseas companies that have not yet fully committed to entering the Japanese market.

Conversations with a carefully selected group of Japanese organizations can help test assumptions around:

• Scientific fit
• Commercial demand
• Competitive positioning
• Evidence requirements
• Potential use cases
• Partnership structures
• Internal decision-making

For example, several organizations may independently tell you that a different use case is more relevant in Japan, that additional validation data are needed, or that the real decision-maker sits in another department.

That information can be valuable even when a meeting does not immediately generate a commercial opportunity.

Instead of evaluating each conversation only as a lead, look for patterns across multiple meetings. Those patterns can help refine your Japan strategy after the event.

Turn Meetings Into a Structured Follow-Up Pipeline

The work should not end when BioJapan closes.

Before the event, decide how you will record and classify each meeting. A simple system might be:

• A — Immediate opportunity. Clear mutual interest and a defined next action.
• B — Longer-term opportunity. Relevant organization, but timing or priorities are not yet aligned.
• C — Market intelligence / ecosystem relationship. No immediate commercial opportunity, but useful information or a strategically relevant relationship.

For each meeting, record:

• Who you met
• Their role
• What they were interested in
• Questions or concerns raised
• Other internal teams mentioned
• Materials promised
• Next action
• Follow-up date

This turns a three-day event into a structured Japan business-development pipeline rather than a collection of business cards.

BioJapan Is One Part of a Japan Market-Entry Strategy

BioJapan creates a concentrated opportunity to meet relevant stakeholders, but it should not be treated as the entire Japan market-entry process.

Not every relevant Japanese organization will necessarily attend the event.

Some companies may attend but not accept a meeting request. Other opportunities may only become visible after early market conversations reveal a new use case or strategic direction.

A broader process might look like this:

• 1. Define the Japan opportunity. Understand where your technology fits within the Japanese scientific and commercial landscape.
• 2. Map the relevant ecosystem. Identify pharmaceutical companies, biotech companies, researchers, institutions, and other relevant stakeholders.
• 3. Prioritize opportunities. Evaluate scientific fit, strategic relevance, potential use cases, and signals of partnership interest.
• 4. Use BioJapan to accelerate conversations. Request meetings with selected targets and gather direct market feedback.
• 5. Follow up and refine the strategy. Continue promising conversations and update your assumptions based on what you learned.

In this sense, BioJapan is not the Japan-entry strategy itself.

It is a high-density opportunity to accelerate a focused Japan market-entry strategy.

Before You Arrive in Yokohama

By the time you arrive at PACIFICO Yokohama, you should ideally know:

• What you want from the Japanese market
• What types of organizations you need to meet
• Which specific organizations are highest priority
• Why your technology may be relevant to each target
• What you want to learn from each meeting
• What a successful next step would look like

BioJapan's Partnering System is designed to help participants approach target organizations before the event rather than depend solely on chance encounters.

But using that system effectively still requires you to decide who is worth targeting.

The goal is therefore not to leave Yokohama with the largest number of business cards.

It is to leave with better market intelligence, stronger relationships, and a clearer understanding of where the real opportunities are in Japan.